Related Experiment Video
Updated: May 14, 2026
09:15
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
[Smoking in COPD]
Celia Zamarro García1, M José Bernabé Barrios, Beatriz Santamaría Rodríguez
1Servicio de Neumología, Hospital Ramón y Cajal, Madrid, España.
Archivos De Bronconeumologia
|January 29, 2013
Summary
Smoking is a chronic, relapsing addictive disease and a major public health issue. Effective, cost-effective treatments exist, with personalized interventions enhancing efficacy for all patients, including those with COPD.
Area of Science:
- Public Health
- Addictive Diseases
- Preventive Medicine
Context:
- Smoking is the leading cause of preventable death and disease globally.
- Tobacco smoke contains over 4,000 toxic chemicals, including 50+ carcinogens.
- Smoking is a significant risk factor for numerous major causes of mortality worldwide.
Purpose:
- To highlight the public health impact of smoking.
- To emphasize the effectiveness and cost-effectiveness of smoking cessation treatments.
- To underscore the importance of personalized therapeutic interventions for smoking addiction.
Summary:
- Smoking is a chronic, relapsing addictive disease causing significant morbidity and mortality.
- Therapeutic interventions for smoking cessation are effective, cost-effective, and safe.
- Personalized treatment strategies improve efficacy, particularly for patients with Chronic Obstructive Pulmonary Disease (COPD) who exhibit higher nicotine dependence.
Impact:
- Smoking cessation is crucial for reducing premature mortality and morbidity.
- Effective treatments can halt disease progression, especially in conditions like COPD.
- Health professionals' interventions yield beneficial results, with personalized approaches maximizing success.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation